Zobrazeno 1 - 10
of 103
pro vyhledávání: '"JJ Molenaar"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/2651667c6e2c42a7a9e46d55e762e367
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss Suppl 1 (2024)
Externí odkaz:
https://doaj.org/article/5b9a32b26b734e11b063dca91eda5078
Publikováno v:
Poster Presentations.
Autor:
J Wienke, LL Visser, WM Kholosy, KM Keller, M Barisa, S Munnings-Tomes, E Carlton, E Poon, A Rodriguez, R Bernardi, F van den Ham, SR van Hooff, KPS Langenberg, FCP Holstege, L Chesler, J Anderson, HN Caron, T Margaritis, MM van Noesel, JJ Molenaar
Publikováno v:
Oral Presentations.
Publikováno v:
Blood, 92(1), 230-233. American Society of Hematology
Europe PubMed Central
Europe PubMed Central
Mutations in the DNA mismatch repair (MMR) system lead to an instability of simple repetitive DNA sequences involved in several cancer types. This instability is reflected in a high mutation rate of microsatellites, and recent studies in colon cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::976c8587d3010e906c1982fcd6a73054
https://pure.amc.nl/en/publications/microsatellite-instability-and-frameshift-mutations-in-bax-and-transforming-growth-factorbeta-rii-genes-are-very-uncommon-in-acute-lymphoblastic-leukemia-in-vivo-but-not-in-cell-lines(ad997b44-491a-467a-8b42-56e04229e19c).html
https://pure.amc.nl/en/publications/microsatellite-instability-and-frameshift-mutations-in-bax-and-transforming-growth-factorbeta-rii-genes-are-very-uncommon-in-acute-lymphoblastic-leukemia-in-vivo-but-not-in-cell-lines(ad997b44-491a-467a-8b42-56e04229e19c).html
Autor:
van Belzen IAEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Tuil M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Badloe S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Janse A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verwiel ETP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Santoso M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Vos S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Baker-Hernandez J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kerstens HHD; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Solleveld-Westerink N; Department of Pathology, UMC Utrecht, Utrecht, the Netherlands., Meister MT; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; UMC Utrecht-Wilhelmina Children's Hospital-Child Health, Utrecht, the Netherlands., Merks JHM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division of Imaging and Oncology, UMC Utrecht and Utrecht University, Utrecht, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Peng WC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tops BBJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Utrecht, the Netherlands. Electronic address: p.kemmeren@prinsesmaximacentrum.nl., Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.y.hehirkwa@prinsesmaximacentrum.nl.
Publikováno v:
Cell genomics [Cell Genom] 2024 Oct 10, pp. 100675. Date of Electronic Publication: 2024 Oct 10.
Autor:
Boer JM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Ilan U; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Boeree A; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Koster J; Amsterdam UMC University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory of Experimental Oncology and Radiobiology Amsterdam The Netherlands., Koudijs MJ; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Center for Translational Immunology UMC Utrecht Utrecht The Netherlands., Rossi C; Department of Pediatric Oncology, Hematology, and Immunology Heidelberg University Hospital Heidelberg Germany., Molenaar JJ; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., Goemans BF; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Department of Pediatric Oncology and Hematology Erasmus Medical Center - Sophia Children's Hospital Rotterdam The Netherlands., Zwaan CM; Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands.; Department of Pediatric Oncology and Hematology Erasmus Medical Center - Sophia Children's Hospital Rotterdam The Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2024 Jul 15; Vol. 8 (7), pp. e122. Date of Electronic Publication: 2024 Jul 15 (Print Publication: 2024).
Autor:
Jeremiasse B; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Bok V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Kleinnijenhuis M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Instituto de Investigaciones Biomedicas Sols-Morreale (IIBM), CSIC-UAM, Madrid, Spain., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Wellens LM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Llibre-Palomar G; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Di Maggio A; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Dekkers JF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Oliveira S; Pharmaceutics, Department of Pharmaceutical Sciences, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG, Utrecht, The Netherlands.; Cell Biology, Neurobiology and Biophysics, Department of Biology, Science Faculty, Utrecht University, 3584 CH, Utrecht, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wijnen MH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Steeg AF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, The Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jul; Vol. 16 (7), pp. 1495-1514. Date of Electronic Publication: 2024 Jun 03.
Autor:
Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.wienke-4@prinsesmaximacentrum.nl., Visser LL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Keller KM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Barisa M; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Poon E; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Munnings-Tomes S; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Himsworth C; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Calton E; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Rodriguez A; Hoffman-La Roche, Basel, Switzerland., Bernardi R; Genentech, A Member of the Roche Group, South San Francisco, CA, USA., van den Ham F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Matser YAH; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tas ML; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lijnzaad P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Borst AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Zappa E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bergsma FJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Strijker JGM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verhoeven BM; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Mei S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA., Kramdi A; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., Restuadi R; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK., Sanchez-Bernabeu A; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Holstege FCP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gray JC; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Scheijde-Vermeulen MA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Straathof K; University College London (UCL) Great Ormond Street Institute of Child Health, London, UK; UCL Cancer Institute, London, UK., Behjati S; Wellcome Sanger Institute, Hinxton, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Department of Paediatrics, University of Cambridge, Cambridge, UK., Wu W; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pharmacy, National University of Singapore, Singapore, Singapore., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Netherlands Proteomics Centre, Utrecht University, Utrecht, the Netherlands., Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, the Netherlands., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Janoueix-Lerosey I; Institut Curie, Inserm U830, PSL Research University, Diversity and Plasticity of Childhood Tumors Lab, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Baryawno N; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden., Chesler L; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Anderson J; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK; Department of Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, England, UK., Caron HN; Hoffman-La Roche, Basel, Switzerland., Margaritis T; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Utrecht, the Netherlands., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Feb 12; Vol. 42 (2), pp. 283-300.e8. Date of Electronic Publication: 2024 Jan 04.
Autor:
Zappa E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Vitali A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. Electronic address: alice.vitali@charite.de., Anders K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands., Wienke J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Künkele A; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113347. Date of Electronic Publication: 2023 Sep 18.